Citation
W. Kreis et D. Budman, Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 34-38
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754
→ ACNP
Volume
26
Issue
5
Year of publication
1999
Supplement
17
Pages
34 - 38
Database
ISI
SICI code
0093-7754(199910)26:5<34:DOEAII>2.0.ZU;2-L